WBA
60
-6
ALL
37
-3
GOOGL
72
5
INTU
62
5
ALLE
35
-2
WEC
43
-2
AA
29
-5
ITW
58
-4
NOV
43
4
NWL
66
-3
ISRG
71
3
HBI
52
4
PNW
59
-4
PM
50
-4
AKAM
61
3
APH
64
3
MCD
57
-5
IR
58
-2
C
60
-2
CMI
58
-2
WBA
60
-6
ALL
37
-3
GOOGL
72
5
INTU
62
5
ALLE
35
-2
WEC
43
-2
AA
29
-5
ITW
58
-4
NOV
43
4
NWL
66
-3
ISRG
71
3
HBI
52
4
PNW
59
-4
PM
50
-4
AKAM
61
3
APH
64
3
MCD
57
-5
IR
58
-2
C
60
-2
CMI
58
-2
Financhill
Back

Cipher Pharmaceuticals 10K Form

Sell
44

CPH.TO
Cipher Pharmaceuticals

Last Price:
14.87
Seasonality Move:
23.68%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CPH.TO News And Ratings

See the #1 stock for the next 7 days that we like better than CPH.TO

CPH.TO Financial Statistics

Sales & Book Value

Annual Sales: $28.56M
Cash Flow: $2.67M
Price / Cash Flow: 20.69
Annual Sales: $5.22
Price / Book: 2.85

Profitability

EPS (TTM): 0.85580
Net Income (TTM): $21.54M
Gross Margin: $23.07M
Return on Equity: 18.47%
Return on Assets: 15.41%

Cipher Pharmaceuticals Earnings Forecast

Key Cipher Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 17 years for CPH.TO is 80.77%.
  • The Selling, General & Administrative Expenses for CPH.TO have been equal to 25.48% of Gross Profit Margin.
  • The Research & Development expenses have been 2.08% of Revenue.
  • The Interest Expense is 1.23% of Operating Income.
  • The Net Earning history of CPH.TO is 96.32% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 11 years.

Cipher Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: TSX
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CPH.TO
CUSIP: 17253X
Website: cipherpharma.com

Debt

Debt-to-Equity Ratio: 0.4
Current Ratio: 2
Quick Ratio: 1.57

Price-to-Earnings

Trailing P/E Ratio: 13.77
Forward P/E Ratio: 0

CPH.TO Technical Analysis vs Fundamental Analysis

Sell
44
Cipher Pharmaceuticals (CPH.TO) is a Sell

Is Cipher Pharmaceuticals a Buy or a Sell?